MolecuLight's Profound Impact on Wound Healing Highlighted in Breaking Clinical Research (Di martedì 6 agosto 2024)
PITTSBURGH, Aug. 6, 2024 /PRNewswire/
MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in Wound care, announces the publication of peer-reviewed Clinical Research highlighting the transformative power of MolecuLight in Healing more pressure injuries with fewer infection complications among 167 Medicare beneficiaries across 55 US-based Long Term Care and Skilled Nursing Facilities. Published by Martha R. Kelso and colleagues, the article entitled "Improving Wound Healing and Infection Control in Long-term Care with Bacterial Fluorescence Imaging" is featured in the latest edition of Advances in Skin & Wound Care journal. The authors report an impressive improvement in pressure injury outcomes among incredibly complex and Healing-challenged patients.Leggi tutta la notizia su liberoquotidiano
Notizie su altre fonti
MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in Wound care, announces the publication of peer-reviewed Clinical Research highlighting the transformative power of MolecuLight in Healing more pressure injuries with fewer infection complications among 167 Medicare beneficiaries across 55 US-based Long Term Care and Skilled Nursing Facilities. Published by Martha R. Kelso and colleagues, the article entitled "Improving Wound Healing and Infection Control in Long-term Care with Bacterial Fluorescence Imaging" is featured in the latest edition of Advances in Skin & Wound Care journal. The authors report an impressive improvement in pressure injury outcomes among incredibly complex and Healing-challenged patients.Leggi tutta la notizia su liberoquotidiano
- MolecuLight's Profound Impact on Wound Healing Highlighted in Breaking Clinical Research - MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, announces the publication of peer-reviewed clinical research highligh ... adnkronos
- MediWound Ltd.: MediWound Announces Positive Results from the U.S. NexoBrid Expanded Access Protocol (NEXT) - Mediwound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced the positive results of ... finanznachrichten.de
- PainReform Ltd. Announces Favorable Wound Healing Data in Human Clinical Trials for PRF-110 - TEL AVIV, Israel, Aug. 05, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ... finance.yahoo
Video MolecuLight Profound
Video MolecuLight Profound
Facebook
Tik Tok
Twitter
Instagram
You Tube
Iscriviti
